Gregory Sargen - Dec 14, 2022 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
Director
Signature
/s/ Stephen Hedberg by Power of Attorney for Gregory P. Sargen
Stock symbol
CDMO
Transactions as of
Dec 14, 2022
Transactions value $
$0
Form type
4
Date filed
12/16/2022, 07:01 PM
Previous filing
Jun 9, 2022
Next filing
Apr 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +4.63K +194.7% 7.01K Dec 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -4.63K -100% $0.00* 0 Dec 14, 2022 Common Stock 4.63K Direct F1, F2
transaction CDMO Restricted Stock Units Award $0 +9.61K $0.00 9.61K Dec 14, 2022 Common Stock 9.61K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022.
F3 Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
F4 The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date.